These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1831014)

  • 21. Ondansetron is effective in decreasing postoperative nausea and vomiting.
    Dershwitz M; Rosow CE; Di Biase PM; Joslyn AF; Sanderson PE
    Clin Pharmacol Ther; 1992 Jul; 52(1):96-101. PubMed ID: 1385567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism and treatment of nausea and vomiting.
    Nagendran T; Nagendran S
    Ala Med; 1990 Nov; 60(5):12-6. PubMed ID: 2291448
    [No Abstract]   [Full Text] [Related]  

  • 23. Ondansetron, clinical development for postoperative nausea and vomiting: current studies and future directions.
    Joslyn AF
    Anaesthesia; 1994 Jan; 49 Suppl():34-7. PubMed ID: 7907459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of postoperative nausea and vomiting using ondansetron, a new, selective, 5-HT3 receptor antagonist.
    Leeser J; Lip H
    Anesth Analg; 1991 Jun; 72(6):751-5. PubMed ID: 1827966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevention and treatment of postoperative nausea and postoperative vomiting with tropisetron].
    Hennes HJ
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Oct; 32(10):628-31. PubMed ID: 9445562
    [No Abstract]   [Full Text] [Related]  

  • 26. [Serotonin antagonists in the treatment of postoperative nausea and vomiting].
    Schousboe BM; Rovsing ML; Knudsen KE; Borgbjerg FM
    Ugeskr Laeger; 1998 Jun; 160(26):3939-43. PubMed ID: 9656839
    [No Abstract]   [Full Text] [Related]  

  • 27. Neither ondansetron nor metoclopramide reduced nausea and vomiting in the emergency department.
    Pitts SR
    Ann Intern Med; 2014 Dec; 161(12):JC3. PubMed ID: 25506875
    [No Abstract]   [Full Text] [Related]  

  • 28. Postoperative nausea and vomiting--its pathophysiology and management.
    Dabbous A
    Middle East J Anaesthesiol; 1996 Jun; 13(5):495-512. PubMed ID: 8994178
    [No Abstract]   [Full Text] [Related]  

  • 29. Ondansetron for postoperative nausea and vomiting.
    Woodward M; Gora ML
    Ann Pharmacother; 1993 Feb; 27(2):188-9. PubMed ID: 8439697
    [No Abstract]   [Full Text] [Related]  

  • 30. Postoperative nausea and vomiting.
    Thompson J
    Br J Theatre Nurs; 1992 Oct; 2(7):22-4. PubMed ID: 1392208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ondansetron and cisplatin-induced nausea and vomiting.
    Hait WN
    N Engl J Med; 1990 Nov; 323(21):1485-6. PubMed ID: 2146502
    [No Abstract]   [Full Text] [Related]  

  • 32. Ondansetron for postoperative nausea and vomiting: decisions in the absence of comparative trials.
    Lewis MA; Fishman DA
    Am J Hosp Pharm; 1994 Feb; 51(4):524-5. PubMed ID: 8017423
    [No Abstract]   [Full Text] [Related]  

  • 33. [Ondansetron (GR 38032F), a competitive 5-HT3 receptor antagonist as an antiemetic in cytostatic drug-induced nausea and vomiting. An open, substance-oriented phase II/III study].
    Serve H; Perker M; Ertl A; Reichold M; Fink U; Berdel WE
    Onkologie; 1990 Oct; 13(5):369-74. PubMed ID: 2150552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The "big little problem" of postoperative nausea and vomiting: do we know the answer yet?
    Fisher DM
    Anesthesiology; 1997 Dec; 87(6):1271-3. PubMed ID: 9416707
    [No Abstract]   [Full Text] [Related]  

  • 35. Ondansetron in the treatment of theophylline overdose.
    Brown SG; Prentice DA
    Med J Aust; 1992 Apr; 156(7):512. PubMed ID: 1532627
    [No Abstract]   [Full Text] [Related]  

  • 36. Prospective evaluation of ondansetron for undifferentiated nausea and vomiting in the prehospital setting.
    Warden CR; Moreno R; Daya M
    Prehosp Emerg Care; 2008; 12(1):87-91. PubMed ID: 18189184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Postoperative nausea and vomiting. Now also a problem for the physician].
    Husum B; Yndgaard S
    Ugeskr Laeger; 1997 Jan; 159(3):263. PubMed ID: 9054064
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of ondansetron in the treatment of emesis induced by non-cisplatin-containing chemotherapy regimes.
    Schmoll HJ
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 1():S35-9. PubMed ID: 2533897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacology and clinical experiences with serotonin (5-HT3) receptor antagonists].
    Scholz J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Oct; 32(10):626-8. PubMed ID: 9445561
    [No Abstract]   [Full Text] [Related]  

  • 40. Cost effective management of postoperative nausea and vomiting (PONV): a multimodal therapeutic approach.
    Gutierrez-Williams G; Goldman M
    Conn Med; 2008 Jan; 72(1):21-4. PubMed ID: 18286879
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.